ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal function"

  • 2022 American Transplant Congress

    Renal Function After Orthotopic Liver Transplantation

    N. Kemmer1, z. Alam2, S. Desai3, L. Grater4, K. Robichaux5, S. Mohammed5, M. Gosselin4, A. Kumar6, J. Buggs7

    1Transplant Hepatology, Tampa General Hospital, Tampa, FL, 2Lake Erie College of Osteopathic Medicine, Bradenton, FL, 3Western University of Osteopathic Medicine, Pomona, CA, 4University of Tampa, Tampa, FL, 5University of South Florida, Tampa, FL, 6Morsani College of Medicine, University of South Florida, Tampa, FL, 7Transplant Surgery, Tampa General Hospital, Tampa, FL

    *Purpose: Patients with end-stage liver disease are susceptible to renal dysfunction especially during liver transplantation (LTX). Continuous renal replacement therapy (CRRT) can be used to…
  • 2022 American Transplant Congress

    Early Experience Of 48-hour Normothermic Machine Perfusion In Human Kidneys Applying Urine Recirculation

    F. Messner1, S. Gasteiger1, M. Pühringer-Sturmayr1, A. Soleiman1, D. Öfner1, S. Schneeberger1, A. Weissenbacher2

    1Medical University of Innsbruck, Innsbruck, Austria, 2Visceral, Transplant and Thoracic Surgery, Medical University of Innsbruck, Innsbruck, Austria

    *Purpose: Normothermic machine perfusion (NMP) of the kidney has been studied extensively during the past decade. Short-term kidney NMP has demonstrated promising results, however currently…
  • 2022 American Transplant Congress

    Evolution of Donor-Derived Cell-Free DNA During the First Week After Surgery Predicts Renal Function Recovery After Kidney Transplantation

    D. Cucchiari1, E. Cuadrado1, E. Gonzalez1, J. Puig1, M. Ramirez-Bajo1, P. Ventura-Aguiar1, I. Revuelta2, B. Bayès1, F. Diekmann1

    1Hospital Clínic de Barcelona, Barcelona, Spain, 2Hospital Clinic de Barcelona, Barcelona, Spain

    *Purpose: Donor-derived cell-free DNA (ddcfDNA) is usually employed starting from the second week after kidney transplantation (KT), as its earlier increase can be due to…
  • 2022 American Transplant Congress

    Single Port Robotic Kidney Transplantation: Comparison of Outcomes with Standard Open Kidney Transplantation

    M. Eltemamy, A. Kaviani, Y. Lin, M. Abou Zeinab, V. Krishnamurthi, D. Goldfarb, J. Kaouk, A. Wee

    Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH

    *Purpose: To compare outcomes of the initial series of patients who underwent single port (SP) robotic kidney transplantation (KTP) with the standard open KTP.*Methods: Using…
  • 2022 American Transplant Congress

    Use of New 2021 CKD-EPI as an Endpoint in Transplant Trials May Significantly Influence Observations

    E. Yanqui1, H. Hames1, T. Shi2, A. R. Shields1, E. S. Woodle1, R. R. Alloway1

    1University of Cincinnati, Cincinnati, OH, 2CCHMC, Cincinnati, OH

    *Purpose: GFR equations have recently been modified primarily to avoid disadvantaging black populations. The purpose of this study was to evaluate renal function and the…
  • 2022 American Transplant Congress

    Longitudinal Mortality Risks and Renal Functional Outcomes in Living Kidney Donors

    K. Hotta1, T. Osawa1, I. Yokota2, T. Inao2, T. Tanabe1, N. Iwahara1, N. Shinohara1

    1Urology, Hokkaido University Hospital, Sapporo, Japan, 2Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    *Purpose: Previous studies have suggested that living kidney donors do not have a higher risk of death or end-stage kidney disease (ESKD) than the general…
  • 2022 American Transplant Congress

    Artificial Mitochondria Transfer to Mitigate Ischemic Damage in an In Vitro Model of Tubular Injury and in an Ex Vivo Porcine Model of DCD Renal Transplantation

    A. Rossi1, S. Sedrakyan2, F. Montali3, C. Aardena4, N. Abraham5, A. Barbas5, L. N. Byers6, C. Palles7, A. Asthana6, J. Robertson4, L. Perin2, R. Senger4, B. Bussolati1, G. Orlando8

    1Un. of Turin, Turin, Italy, 2Children Hospital, Los Angeles, CA, 3Un. of L'Aquila, L'Aquila, Italy, 4VA Tech, Blacksburg, VA, 5Duke, Durham, NC, 6WFIRM, Winston Salem, NC, 7University of Florida, Gainesville, FL, 8Wake Forest Baptist, Winston-Salem, NC

    *Purpose: We aimed at assessing whether artificial mitochondrial transfer (AMT) mitigates renal injury in an in vitro model of tubular damage and in an ex…
  • 2022 American Transplant Congress

    Cytomegalovirus Prevention in Kidney and Pancreas Transplant Recipients: A Successful Pharmacist-Led Multidisciplinary Approach

    J. Geyston, J. Dann, A. Doyle, A. Agarwal, K. Brayman, C. Shoemaker, C. Lester, S. Rao

    University of Virginia Health, Charlottesville, VA

    *Purpose: In response to high cytomegalovirus (CMV) infection and increasing ganciclovir (GCV)-resistance rate, a pharmacist-led multidisciplinary task force was created to manage CMV prophylaxis (ppx).…
  • 2022 American Transplant Congress

    Tocilizumab in Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: A Case Series

    B. Boonpheng1, R. Bakthavatsalam2, C. D. Blosser1, I. C. De Castro1, I. Gimferrer3, Y. Ng1, N. Leca1

    1Nephrology, University of Washington, Seattle, WA, 2Surgery, University of Washington, Seattle, WA, 3Bloodworks Northwest, Seattle, WA

    *Purpose: The optimal treatment for chronic active antibody-mediated rejection (ca-AMR) remains unclear. Tocilizumab (TCZ), a monoclonal antibody against IL-6, has been proposed in ca-AMR treatment…
  • 2022 American Transplant Congress

    Impact of Delayed Graft Function in Donation After Circulatory Death Kidney Transplantation

    J. Mello Offerni1, H. Brar1, D. Lee1, M. Levine2, M. Mandurah1, S. Rim1, A. Sener1, P. Luke1

    1Urology, Western University, London, ON, Canada, 2Division of Urology, Department of Surgery, University of Alberta, Edmonton, AB, Canada

    *Purpose: Donation after circulatory death (DCD) has been associated with higher rates of delayed graft function (DGF) when compared to donation after brain death (DBD).…
  • 1
  • 2
  • 3
  • …
  • 27
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences